Karen To - Concepedia

Author

Karen To

University of British Columbia

Also Known As

K To, K. To, Karen To, To, Karen Ka-Yan

Publications

952

Citations

H-Index

Concepts

All Affiliations

University of British Columbia Child and Family Research Institute BC Cancer Agency Wake Forest University Health Sciences Centre

About

Karen To is an author at University of British Columbia specializing in medicine, cell biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	656
2	Cell Biology	4	4	555
3	Public Health	1	1	101
4	Molecular Biology	1	1	94
5	Neurology	1	1	101

Karen To

Publications

950

Citations

H-Index

Page 1

	Year	Citations
Transcriptome Analysis of the Normal Human Mammary Cell Commitment and Differentiation Process Afshin Raouf, Yun Zhao, Karen To, Cell stem cell Cell LineageTranscriptome AnalysisDevelopmental BiologyMammary GlandTranscriptomics Technology	2008	354
Y-Box Binding Protein-1 Induces the Expression of <i>CD44</i> and <i>CD49f</i> Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance Karen To, Abbas Fotovati, Kristen M. Reipas, Cancer Research	2010	166
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial Shelagh B. Coutts, Sandeep Ankolekar, Ramana Appireddy, The Lancet ThrombosisSuperiority TrialIschemic StrokeCardiovascular DiseaseMedicine	2024	101
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells Melanie Finkbeiner, Arezoo Astanehe, Karen To, Oncogene Breast OncologySignaling PathwayMet Receptor RegulationNew MechanismMolecular Biology	2009	94
The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1 Arezoo Astanehe, Melanie Finkbeiner, Payman Hojabrpour, Oncogene Tumor BiologyTranscriptional RegulationSignal TransductionSignaling PathwayCell Regulation	2009	74
Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability Jennifer Law, Yvonne Li, Karen To, PLoS ONE	2010	50
Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019 Swapnil Hiremath, Peter G. Blake, Angie Yeung, Clinical Journal of the American Society of Nephrology	2023	45
Genomic Instability of Human Mammary Epithelial Cells Overexpressing a Truncated Form of EMSY Afshin Raouf, Lindsay Brown, Nikoleta Vrcelj, JNCI Journal of the National Cancer Institute Genomic MechanismEmsy ProteinCancer BiologyTumor BiologyGenomic Instability	2005	33
The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor Karen To, Yi Zhao, Helen Jiang, Molecular Pharmacology	2007	33

Page 1